Clinical Trial Update: Framingham: Inflammation, Genes & Cardiovascular Disease

View source ↗

Summary

A completed update for the Framingham study investigating inflammation, genetics, and cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases

Snippet

Sponsor: Boston University | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED